She brings nearly a decade of experience working in-house at national law firms to Signal, where she applies best practices in contemporary mass media to modernize class action notice programs. Kristen has led the design of comprehensive notice plans for some of the country’s largest and most high-profile settlements, including In re: Equifax, Inc., Customer Data Security Breach Litigation, and has appeared in court to present to judges on the impacts of Signal programs.
Kristen’s extensive work with clients informs her unique legal marketing and personalized outreach methods across media. Prior to joining Signal, Kristen worked at a San Francisco personal injury practice where she provided Spanish legal translation and interpretation services and helped prepare attorneys for trial. She has managed hundreds of cases and lien resolution in mass tort litigation, including in product liability cases concerning Pradaxa (Dabigatran Etexilate), Yasmin and Yaz (Drospirenone), Actos (Pioglitazone), Granuflo/Naturalyte Dialysate, Risperdal (Risperidone), Testosterone Replacement Therapy Products, and Taxotere (Docetaxel).
Kristen has a certificate in HIPAA Compliance for Business Associates.